Covidien Pipeline™ Vantage Embolization Device with Shield Technology™ - HSA Registration DE0505750
Access comprehensive regulatory information for Covidien Pipeline™ Vantage Embolization Device with Shield Technology™ in the Singapore medical device market through Pure Global AI's free database. This CLASS D medical device is registered under HSA registration number DE0505750 and owned by Micro Therapeutics, Inc. d/b/a EV3 Neurovascular. The device was registered on May 03, 2021.
This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.
The Pipeline™ Vantage Embolization Device with Shield Technology™ is indicated for endovascular embolization of cerebral aneurysms

